Names and pronunciation
(a-fli-ber′sept) Eylea
PDF page 42
Drug reference
(a-fli-ber′sept) Eylea
PDF page 42
Func. class.: Vascular endothelial growth factor inhibitor signal transduc- tion inhibitor (STI) (ophthalmic)
PDF page 42
USES: For treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema after central reti- nal vein occlusion, diabetic retinopathy with diabetic macular edema
PDF page 42
DOSAGE AND ROUTES Neovascular age-related macular degeneration (wet) Adult: Intravitreal injection 2 mg (0.05 mL) into affected eye q4wk × 12 wk, then 2mg q8wk Diabetic macular edema/retinopathy Adult: Intravitreal injection 2 mg (0.05 mL) q4wk × 5 injections, then 2 mg (0.05 mL) q8wk Macular edema Adult: Intravitreal injection: 2 mg (0.05 mL) q4wk
PDF page 42
Available forms: Intravitreal injection 2 mg (0.05 mL) single-use vial • Adult: Intravitreal injection 2 mg (0.05 mL) into affected eye(s) q4wk × 12 wk, then 2 mg (0.05 mL) q8wk
PDF page 42